All Articles on Vaccine
Vaccine hesitancy in the time of COVID-19Can lessons from Immunity Community help build acceptance of COVID-19 vaccines? Clarissa Hsu, PhD, thinks so.
Flu shot Q & A: Does COVID-19 change our approach?KPWHRI’s Michael L. Jackson, PhD, MPH, talks about influenza vaccine research in the age of the pandemic.
COVID-19 vaccine well tolerated, generates immune responseNational Institute of Allergy and Infectious Diseases-sponsored phase 1 trial tested mRNA vaccine.
5 questions with an influenza and COVID-19 epidemiologistDr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
Coronavirus vaccine trial now includes older peopleLed by Dr. Lisa A. Jackson, first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded.
Research versus COVID-19From clinical trials to technical support, Dr. Rita Mangione-Smith describes how Kaiser Permanente Washington researchers are fighting the novel coronavirus.
Kaiser Permanente launches first coronavirus vaccine trialOn March 16, 4 volunteers received an injection of an mRNA vaccine for COVID-19 in NIH-funded trial in Seattle.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.